Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
New study examines trends in liquid laundry detergent packet exposures among young children

New study examines trends in liquid laundry detergent packet exposures among young children

UMass Amherst researcher aims to tackle bone damage in metastatic cancer

UMass Amherst researcher aims to tackle bone damage in metastatic cancer

Discovery of toxic and protective short RNAs associated with Alzheimer's disease and superior memory capacity

Discovery of toxic and protective short RNAs associated with Alzheimer's disease and superior memory capacity

Unveiling the cellular mechanisms of engram consolidation and memory refinement

Unveiling the cellular mechanisms of engram consolidation and memory refinement

Clinical study suggests statins could be key in reducing dementia in individuals with heart failure

Clinical study suggests statins could be key in reducing dementia in individuals with heart failure

Wireless magnetogenetic approach could be used to treat motor dysfunction in people with Parkinson’s disease

Wireless magnetogenetic approach could be used to treat motor dysfunction in people with Parkinson’s disease

UNC scientists develop "smart" patch for precision drug delivery

UNC scientists develop "smart" patch for precision drug delivery

Short strands of toxic RNAs contribute to brain cell death and DNA damage in Alzheimer's

Short strands of toxic RNAs contribute to brain cell death and DNA damage in Alzheimer's

23% of dementia cases linked to controllable risk factors vary by race and ethnicity

23% of dementia cases linked to controllable risk factors vary by race and ethnicity

Migraine disability worsens with stigma, study reveals

Migraine disability worsens with stigma, study reveals

Researchers receive $24 million grant to extend the 'Study Of Healthy Aging in African Americans'

Researchers receive $24 million grant to extend the 'Study Of Healthy Aging in African Americans'

Unlocking the anti-inflammatory secrets of bergamot byproducts

Unlocking the anti-inflammatory secrets of bergamot byproducts

Research projects aim to develop breakthrough digital technology for improving heart and brain health

Research projects aim to develop breakthrough digital technology for improving heart and brain health

Cedars-Sinai pioneers method to identify dementia patients for better care

Cedars-Sinai pioneers method to identify dementia patients for better care

Research reveals the function of a little-understood junction between brain cells

Research reveals the function of a little-understood junction between brain cells

Alzheimer's disease found to have five distinct subtypes

Alzheimer's disease found to have five distinct subtypes

Dutch scientists uncover five different biological variants of Alzheimer's disease

Dutch scientists uncover five different biological variants of Alzheimer's disease

Ginseng's hidden gems: Rare ginsenosides emerge as potent players in the future of medicine

Ginseng's hidden gems: Rare ginsenosides emerge as potent players in the future of medicine

Photobiomodulation alleviates Aβ deposition and cognitive decline in mice with Alzheimer’s disease

Photobiomodulation alleviates Aβ deposition and cognitive decline in mice with Alzheimer’s disease

Tailored approach needed to bridge quality-of-care divide in dementia nursing homes

Tailored approach needed to bridge quality-of-care divide in dementia nursing homes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.